Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 34, Issue 12, 2007, Pages 2481-2485

  Vojvodich, Paola Fernandez ^a   Hansen, Jes B ^b   Andersson, Ulf ^a   Sävendahl, Lars ^a   Hagelberg, Stefan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Epidemiology ^*  (Denmark)

Author keywords

Etanercept; Growth; Juvenile idiopathic arthritis; Puberty

Indexed keywords

ETANERCEPT; GLUCOCORTICOID; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GROWTH; HUMAN; INFORMATION PROCESSING; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PUBERTY; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 36849023492     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Elliott MJ, Maini RN, Feldmann M, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
2. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999;130:478-86.
3. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.
4. Lovell DJ, Reiff A, Jones OY, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:1987-94.
5. St. Clair EW, van der Heijde DM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis; a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
6. Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
7. Polito C, Strano CG, Olivieri AN, et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997;26:99-103.
8. Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P. Treatment of growth failure in juvenile chronic arthritis. Horm Res 2002;58 Suppl 1:28-32.
9. Martensson K, Chrysis D, Savendahl L. Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004;19:1805-12.
10. Schmeling H, Seliger E, Horneff G. Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin Exp Rheumatol 2003;21:779-84.
11. Tynjala P, Lahdenne P, Vahasalo P, Kautiainen H, Honkanen V. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 2006;65:1044-9.
12. Karlberg P, Taranger J. The somatic development of children in a Swedish urban community. Acta Paediatr Scand Suppl 1976:1-148.
13. Chrysis D, Ritzen EM, Savendahl L. Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes. J Endocrinol 2003;176:331-7.
14. Saha MT, Verronen P, Laippala P, Lenko HL. Growth of prepubertal children with juvenile chronic arthritis. Acta Paediatr 1999;88:724-8.
15. Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P. Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 2003;30:2492-9.
16. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.